Canagliflozin is a C-glycosyl compound that functions as an inhibitor of sodium-glucose transport protein subtype 2. It is utilized as a hypoglycemic agent and is employed in pharmaceutical manufacturing for the management of type II diabetes.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 928672-86-0
Kanagliflozin
active pharmaceutical ingredient
Seladelpar lysine
active pharmaceutical ingredient
Elinzanetant
non-hormonal NK-1 and NK-3 receptor antagonist
Dotarem
MRI contrast agent
Guaifenesin
Expectorant active pharmaceutical ingredient
(1S)-2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-D-glucitol
pharmaceutical intermediate
D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, 2,3,4,6-tetrakis(2,2-dimethylpropanoate), (1S)-
research compound
(2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
XTNGUQKDFGDXSJ-ZXGKGEBGSA-N
CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F